Importantly, TP53 status has been shown to affect prognosis in patients with colon cancer because patients with p53 mutant colorectal cancer have poorer survival outcomes than patients with p53 wild-type cancer [32,33]. This evidence concerns the gene TP53 and colorectal cancer.